Frances Rocamora - Concepedia

Author

Frances Rocamora

University of California San Diego ORCID

Also Known As

Frances Maureen C. Rocamora, Frances Maureen Rocamora, Frances Rocamora, Rocamora, Frances, Rocamora, Frances Maureen C.

Publications

507

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Wellcome Sanger Institute Columbia University Irving Medical Center Scripps Research Institute Mahidol Oxford Tropical Medicine Research Unit

About

Frances Rocamora is an author at University of California San Diego specializing in natural sciences, malaria, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	274
2	Natural Sciences	3	3	274
3	Biochemistry	2	2	202
4	Biology	1	1	72
5	Immunology	1	1	181

Frances Rocamora

Publications

400

Citations

H-Index

Page 1

	Year	Citations
Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites Frances Rocamora, Lei Zhu, Kek Yee Liong, PLoS Pathogens Antiparasitic AgentMalariaImmunologyMolecular BiologyArtemisinin Resistance	2018	181
The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background Lei Zhu, Jaishree Tripathi, Frances Rocamora, Nature Communications Malaria Artemisinin ResistanceGeneticsMalariaMolecular BiologyMolecular Genetics	2018	72
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway Gregory LaMonte, Frances Rocamora, Danushka S. Marapana, Nature Communications	2020	50
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target Eva S. Istvan, Francisco M. Guerra, Matthew Abraham, Science Translational Medicine	2023	26
Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome Inhibitors Jehad Almaliti, Pavla Fajtová, Jaeson Calla, Chemistry - A European Journal Vitro PotencyMolecular PharmacologyMedicinal ChemistryBiochemistryAntiparasitic Agent	2023	21
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i> Frances Rocamora, Purva Gupta, Eva S. Istvan, ACS Infectious Diseases	2021	20
Systematic in vitro evolution in <i>Plasmodium falciparum</i> reveals key determinants of drug resistance Madeline R. Luth, Karla P. Godinez‐Macias, Daisy Chen, Science	2024	18
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer Yabalu Z. Abacha, Arnold Donkor Forkuo, Stephen Yao Gbedema, Frontiers in Pharmacology	2022	12

Page 1